Automated circumferential Barrett's ablation by using radiofrequency energy: a welcome step in the right direction

Gastrointestinal Endoscopy

Volumn 65, Issue 2, 2007, Pages 196-199

  Weston, Allan P ^a  

^a Freeman Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; BALLOON CATHETER; BARRETT ESOPHAGUS; DYSPHAGIA; EDITORIAL; ENDOSCOPIC SURGERY; ESOPHAGUS MUCOSA; GENERATOR; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MICROELECTRODE; ODYNOPHAGIA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SAFETY; SORE THROAT; SYMPTOM; THORAX PAIN; TREATMENT OUTCOME;

BARRETT ESOPHAGUS; BIOPSY; CATHETER ABLATION; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS;

EID: 33846534319     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.11.005     Document Type: Editorial

References (34)

1. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
2. Sharma P., Wani S., Weston A.P., et al. A randomized controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long-term results. Gut 55 (2006) 1233-1239
3. Manner H., May A., Miehlke S., et al. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol 101 (2006) 1762-1769
4. Dulai G.S., Jensen D.M., Cortina G., et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61 (2005) 232-240
5. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 95 (2000) 1661-1668
6. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 (2001) 554-558
7. Ragunath K., Krasner N., Raman V.K., et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40 (2005) 750-758
8. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-does omeprazole. Gastrointest Endosc 51 (2000) 659-663
9. Morris C.D., Byrne J.P., Armstrong G.R., et al. Prevention of neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation. Br J Surg 88 (2001) 1357-1362
10. Basu K.K., Pick B., Bale R., et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 51 (2002) 776-780
11. Van Laethem J.L., Cremer M., Peny M.O., et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43 (1998) 747-751
12. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device (BARRX). Surg Endosc 20 (2006) 125-130
13. Panjehpour M., Overholt B.F., DeNovo R.C., et al. Centering balloon to improve esophageal photodynamic therapy. Lasers Surg Med 12 (1992) 631-638
14. Gurski R.R., Peters J.H., Hagen J.A., et al. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196 (2003) 706-713
15. Abbas A.E., Deschamp C., Cassivi S.D., et al. Barrett's esophagus: the role of laparoscopic fundoplication. Ann Thorac Surg 77 (2004) 393-396
16. Oelschlager B.K., Barreca M., Chang L., et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 238 (2003) 458-466
17. Salo J.A., Salminen J.T., Kiviluoto T.A., et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227 (1998) 40-44
18. Pinotti A.C., Cecconello I., Filho F.M., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 17 (2004) 243-246
19. Ackroyd R., Tam W., Schoeman M., et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrointest Endosc 59 (2004) 66-69
20. Pagani M., Granelli P., Chella B., et al. Barrett's esophagus: combined treatment using argon plasma coagulation and laparoscopic antireflux surgery. Dis Esophagus 16 (2003) 279-283
21. Morino M., Rebecchi F., Giaccone C., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 17 (2003) 539-542
22. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 (1999) 173-177
23. Bowers S.P., Mattar S.G., Waring P.J., et al. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Surg Endosc 17 (2003) 49-54
24. Wani S., Sampliner R.E., Weston A.P., et al. Lack of predictors of normalization of oesophageal acid exposure in Barrett's esophagus. Aliment Pharmacol Ther 22 (2005) 627-633
25. Sarela A.I., Hick D.G., Verbeke C.S., et al. Persistent acid and bile reflux in asymptomatic patients with Barrett's esophagus receiving proton pump inhibitor therapy. Arch Surg 139 (2004) 547-551
26. Todd J.A., Basu K.K., and Caestecker J.S.D. Normalization of oesophageal pH does not guarantee control of duodenogastric-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 21 (2005) 969-975
27. Oberg S., Peters J.H., DeMeester T.R., et al. Determinants of intestinal metaplasia within the columnar-lined esophagus. Arch Surg 135 (2000) 651-655
28. Weston A.P., Sharma P., Banerjee S.K., et al. Visible endosocpic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc 61 (2005) 515-521
29. Sampliner R.E., Camargo E., and Prasad A.R. Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. Dis Esophagus 19 (2006) 277-279
30. Avidan B., Sonnenberg A., Schnell T.G., et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97 (2002) 1930-1936
31. Weston A.P., Sharma P., Mathur S., et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 99 (2004) 1657-1666
32. Teodori L., Gohde W., Persiana M., et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 34 (1998) 257-263
33. Reid B.J., Levine D.S., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high risk patient subsets. Am J Gastroenterol 95 (2000) 1669-1676
34. Reid B.J., Prevo L.J., Galipeau P.C., et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96 (2001) 2839-2848